MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Veracyte Inc

Closed

SectorHealthcare

29.5 -0.2

Overview

Share price change

24h

Current

Min

28.83

Max

30.48

Key metrics

By Trading Economics

Income

-10M

5.1M

Sales

2.8M

119M

P/E

Sector Avg

95.645

63.778

EPS

0.36

Profit margin

4.31

Employees

824

EBITDA

-13M

9.7M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+50.79% upside

Dividends

By Dow Jones

Next Earnings

6 maj 2025

Market Stats

By TradingEconomics

Market Cap

-1.2B

2.3B

Previous open

29.7

Previous close

29.5

News Sentiment

By Acuity

12%

88%

21 / 386 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Veracyte Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

1 kwi 2025, 23:15 UTC

Major Market Movers

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

1 kwi 2025, 23:46 UTC

Market Talk

Market Grapples With Valuing Goodman's Data Centers -- Market Talk

1 kwi 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 kwi 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

1 kwi 2025, 23:44 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

1 kwi 2025, 23:43 UTC

Market Talk

Gold Steady, Underpinned by Signs of Chinese Buying Activity -- Market Talk

1 kwi 2025, 23:11 UTC

Top News

Risk Off Trade Is Getting Crowded. It's More Worry Than Panic. -- Barrons.com

1 kwi 2025, 23:02 UTC

Market Talk

New Zealand May Be Measuring Stick for Trade-War Fallout -- Market Talk

1 kwi 2025, 22:31 UTC

Top News

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 kwi 2025, 22:26 UTC

Market Talk

RBA's Focus on What It Doesn't Know Boosts May Cut Odds -- Market Talk

1 kwi 2025, 21:47 UTC

Top News

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 kwi 2025, 21:32 UTC

Top News

Hooters' Bankruptcy Is the Latest Sign of Trouble for Restaurants -- Barrons.com

1 kwi 2025, 21:06 UTC

Market Talk

Mexican Remittances See Slow Start to the Year -- Market Talk

1 kwi 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

1 kwi 2025, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

1 kwi 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 kwi 2025, 20:47 UTC

Top News

Boeing Stock Drops. Why Lower 737 MAX Production Report Wasn't Quite Right. -- Barrons.com

1 kwi 2025, 20:47 UTC

Top News

BYD Will Beat Tesla Two Ways This Quarter -- Barrons.com

1 kwi 2025, 20:20 UTC

Top News

Trump's 'Liberation Day' Tariffs Loom; Treasury Yields Fall -- WSJ

1 kwi 2025, 20:15 UTC

Acquisitions, Mergers, Takeovers

Eaton Completes Acquisition Of Fibrebond >ETN

1 kwi 2025, 20:11 UTC

Market Talk

Altria Stock Seen Overvalued Amid Steep Volume Losses -- Market Talk

1 kwi 2025, 20:07 UTC

Acquisitions, Mergers, Takeovers

Johnson & Johnson Intends to Complete Its Acquisition of Intra-Cellular Therapies on or Around April 2 >JNJ

1 kwi 2025, 20:00 UTC

Top News

Americans Are Worried About Tariffs. Consumer Stocks Could Take a Hit. -- Barrons.com

1 kwi 2025, 19:46 UTC

Top News

Visa, American Express Bidding to Win Apple Credit-Card Network, Sources Say -- WSJ

1 kwi 2025, 19:43 UTC

Market Talk

Oil Rally Loses Momentum Ahead of U.S. Tariff Plans -- Market Talk

1 kwi 2025, 19:17 UTC

Top News

Meta's Head of AI Research to Resign Amid Computing Push -- Update

1 kwi 2025, 19:13 UTC

Market Talk

U.S. Natural Gas Futures Give Back Gains -- Market Talk

1 kwi 2025, 19:03 UTC

Market Talk

Don't Rush Into Trade Talks With U.S., Canadian Experts Advise Lawmakers -- Market Talk

1 kwi 2025, 19:00 UTC

Market Talk

Gold Slips Ahead of Tariff Day -- Market Talk

1 kwi 2025, 18:54 UTC

Market Talk

Mexican Manufacturing PMIs Reflect Tariff Threats -- Market Talk

Peer Comparison

Price change

Veracyte Inc Forecast

Price Target

By TipRanks

50.79% upside

12 Months Forecast

Average 44.71 USD  50.79%

High 51 USD

Low 29 USD

Based on 8 Wall Street analysts offering 12 month price targets forVeracyte Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

0

Hold

1

Sell

Technical Score

By Trading Central

29.65 / 31.78Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

21 / 386 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.